证券代码：300302 证券简称：同有科技 公告编号：2026-002 北京同有飞骥科技股份有限公司 关于持股 5%以上股东股权提前解除质押的公告 截至本次解除股份质押日，上述股东及其一致行动人所持质押股份情况如下： 股东 名称 持股数量 （股） 持股 比例 累计质押 股份数量 （股） 占其所 持股份 比例 占公司 总股本 比例 已质押股份 情况 未质押股份 情况 已质押股份 限售和冻结 数量（股） 占已质押 股份比例 未质押股份限 售和冻结数量 （股） 占未质押股 份比例 佟易 虹 52,049,801 10.86% 0 0.00% 0.00% 0 0.00% 39,314,851 75.53% 总计 52,049,801 10.86% 0 0.00% 0.00% 0 0.00% 39,314,851 75.53% 二、备查文件 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 北京同有飞骥科技股份有限公司（以下简称"公司"）接到持股 5%以上股东 佟易虹先生关于将其所持有的本公司股权办理了股票提前解除质押业务的通知， 具体情况如下： 一、股东股份质押的基本情 ...

证券代码：300302 证券简称：同有科技 公告编号：2026-001 北京同有飞骥科技股份有限公司 北京同有飞骥科技股份有限公司 董 事 会 关于持股 5%以上股东减持股份触及 1%整数倍的公告 持股 5%以上的股东杨永松先生保证向本公司提供的信息内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 | 1、基本情况 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 信息披露义务人 | 杨永松 | | | | | | | 住所 | 北京市海淀区闵庄路 | | | | | | | 权益变动时间 | 2025 年 25 日至 1 月 日 | 12 月 | 2026 | 年 | 5 | | | 权益变动过程 | 信息披露义务人杨永松先生因自身资金需求，自 2025 25 日至 年 1 月 日通过集中竞价交易减持公司股份 股，占公司总股本的 0.5816%，持有公司股份比例由 2,787,637 7.3819%下降至 6.8002%，变动触及 1%的整数倍。本次减持严 格按照已披露的《关于持股 5%以上股东减持股份预披露公告》 | 202 ...

Group 1 - The company focuses on the research and development of domestically produced, self-controllable storage solutions [1] - The company is highly attentive to industry dynamics and trends in AI technology [1]

Core Viewpoint - The company is enhancing its self-developed storage system performance by integrating technological resources from upstream investment targets, Yiheng Chuangyuan and Zeshite Technology [1] Group 1 - The company is adjusting the production pace at its Changsha base according to existing order delivery requirements and potential order expectations [1] - Production at the Changsha base and other facilities is proceeding in an orderly manner, ensuring high-quality delivery of company orders [1]

Core Viewpoint - The company is actively monitoring the price trends of upstream raw materials and is taking proactive measures to manage costs and pricing strategies in response to market conditions [1] Group 1 - The company is focusing on the price trends of raw materials and has been stocking up on certain materials that have seen significant price increases [1] - The company plans to adjust product prices based on changes in raw material costs and downstream market demand [1]

证券代码：300302 证券简称：同有科技 公告编号：2025-053 北京同有飞骥科技股份有限公司 关于持股 5%以上股东减持股份触及 1%整数倍的公告 持股 5%以上的股东佟易虹先生保证向本公司提供的信息内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 北京同有飞骥科技股份有限公司（以下简称"公司"）于 2025 年 12 月 2 日 在巨潮资讯网（www.cninfo.com.cn）披露了《关于持股 5%以上股东减持股份预 披露公告》（公告编号：2025-048）。持有本公司股份 53,599,919 股（占本公司总 股本比例 11.1838%）的股东、董事佟易虹先生计划在上述公告披露日起 15 个交 易日后的 3 个月内（法律法规禁止减持的期间除外）以集中竞价方式减持本公司 股份不超过 4,792,637 股，即不超过公司总股本的 1.0000%，未超过其所持有公 司股份总数的 25%。 近日，公司收到佟易虹先生出具的《股份减持计划实施情况告知函》，佟易 虹先生自 2025 年 12 月 24 日至 2025 年 12 月 ...

Group 1 - The company is continuously monitoring market dynamics and adjusting product prices based on upstream procurement costs and downstream market demand changes [2]

Core Viewpoint - The company has achieved large-scale application of its self-controlled storage system products in satellite big data scenarios, providing efficient solutions for the entire chain of real-time stream data reception, data parsing, data processing, and storage [1] Group 1 - The company's storage system products are designed for satellite big data applications [1] - The solutions offered cover the complete process from data reception to storage [1]

Core Viewpoint - Tongyou Technology announced the approval of a proposal to apply for a credit limit from a bank during the fifteenth meeting of its fifth board of directors [2] Group 1 - The company held its fifteenth meeting of the fifth board of directors on December 19 [2] - The board approved a proposal regarding the application for a credit limit from a bank [2]

Group 1 - Sichuan Chengyu's wholly-owned subsidiary plans to acquire 85% equity of Hubei Jingyi Company for 2.409 billion yuan, enhancing the company's control over highway projects [1] - Huadian Technology signed contracts worth approximately 815 million yuan with Huadian Technology Group for a wind power hydrogen production project [2] - Dongfang Cable and its subsidiary won projects totaling approximately 3.125 billion yuan, accounting for 34.37% of the company's audited revenue for 2024 [3] Group 2 - Heng Rui Medicine received approval for clinical trials of SHR-2906 injection, a self-developed biopharmaceutical aimed at weight control and metabolic regulation [4] - Qingdao Port plans to invest approximately 15.7 billion yuan in two terminal projects [5] - Jingu Co. received a notification to supply low-carbon wheels for two export models to a major domestic car manufacturer, with production expected in 2026 [6] Group 3 - ST Xingguang won a procurement project worth approximately 22.955 million yuan, accounting for 11.96% of the company's revenue for 2024 [7] - Xinbo Co. plans to jointly invest in an alloy materials research institute with partners, focusing on high-performance materials for various industries [8] - Tianqi Lithium's third-phase lithium concentrate expansion project has been completed and is undergoing trial production, with a total capacity of 2.14 million tons per year [9] Group 4 - Changfei Fiber reported that new fiber optic products related to data centers represent a small proportion of total demand [10] - Dongfang Bio's subsidiaries obtained multiple medical device registration certificates, including various testing kits [11] - Xiugang Co. plans to use up to 500 million yuan of idle fundraising for cash management in safe, liquid investment products [12] Group 5 - Jifeng Co. received a project designation for passenger car seat assemblies from a European luxury brand, with a total lifecycle value of approximately 9.8 billion yuan [13] - CanSino initiated Phase I clinical trials for a combined vaccine, completing the first subject enrollment [14] - Dayu Water-saving's subsidiary pre-won a drainage project worth 140 million yuan and another project worth 1 billion yuan [15] Group 6 - Yutong Pharmaceutical's subsidiary received clinical trial approval for YKYY032 injection for treating hyperlipoproteinemia [17] - Diweier announced the departure of a core technical personnel, impacting its technical leadership [18] - Weilang Co.'s controlling shareholder received regulatory measures from the Shandong Securities Regulatory Bureau for failing to fulfill a commitment [19] Group 7 - Xiehe Electronics invested 5 million yuan in a private equity fund focusing on hard technology sectors [20] - Phoenix Optical received a government subsidy of 4.7053 million yuan, representing 35% of its projected net profit for 2024 [21] - China State Construction reported a 0.9% year-on-year increase in new contracts signed in the first 11 months of 2025, totaling 4.0408 trillion yuan [22] Group 8 - Nanguang Energy's pumped storage power station units 1 and 2 have entered trial operation, with units 3 and 4 expected to follow by year-end [23] - Jindalai plans to invest 280 million yuan to acquire a 34% stake in Yunnan Jici Medical Technology [24] - Geer Software terminated its planned acquisition of a majority stake in Weipin Zhiyuan due to failure to reach agreement on key terms [25] Group 9 - Ningbo Fubang completed the absorption merger of its wholly-owned subsidiary, inheriting all assets and liabilities [26] - Zhongyuan Neipei signed a strategic cooperation framework agreement with Ningbo Puzhi Company for humanoid robot-related business [28] - Gongyuan Co. announced a business integration and relocation of its production lines in the East China region [29] Group 10 - Chlor-alkali Chemical's subsidiary plans to invest 2.975 billion yuan in a comprehensive utilization project for waste salt [30] - Kain Technology announced the departure of a core technical personnel, impacting its research capabilities [31] - ST Renfu received approval for clinical trials of a new drug for idiopathic pulmonary fibrosis [32] Group 11 - Sanbo Brain Science's established brain science fund has completed registration with the Asset Management Association of China [33] - Tongyou Technology plans to apply for a 70 million yuan credit line from Beijing Bank, using its property as collateral [34] - Bai Ao Intelligent signed a significant equipment sales contract worth approximately 27.5021 million yuan [35] Group 12 - ST Xinyan received all restructuring investment funds totaling 2.239 billion yuan, entering the execution phase of its restructuring plan [36] - Dalu Real Estate's subsidiary decided to terminate a planned acquisition of a 60% stake in Beijing Chengzhu Real Estate [38] - Huiyu Pharmaceutical's products received marketing approval in Italy and Norway [39]